PANTOLOC 20 MG
PANTOPRAZOLE (PANTOPRAZOLE SODIUM) : 20 MG · DIN 02241804 · TAKEDA CANADA INC
Health Canada status: MARKETED
What is PANTOLOC?
PANTOLOC 20 MG contains PANTOPRAZOLE (PANTOPRAZOLE SODIUM) : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02241804, held by TAKEDA CANADA INC, supplied as TABLET (ENTERIC-COATED) for ORAL administration. Health Canada currently lists it as marketed, status dated 09-Jan-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PANTOLOC used for?
PANTOLOC® (pantoprazole sodium) is indicated for the treatment of conditions where a reduction of gastric acid secretion is required, such as: Duodenal ulcer, Gastric ulcer, Reflux esophagitis, Symptomatic gastro-esophageal reflux d isease (such as, acid regurgitation and heartburn), Prevention of gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs (NSAIDs) in patients with a need for continuous NSAID treatment, who have increased risk to develop NSAID-associated upper gastrointestinal lesions, and Helicobacter pylori (H. pylori) associated duodenal ulcer. Pantoprazole, in combination with clarithromycin and either amoxicillin or metronidazole, is indicated for the treatment of patients with an active duodenal ulcer who are H. pylori positive.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is PANTOLOC called?
The same molecule, PANTOPRAZOLE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Somac | Latin | Australia |
| APO-Pantoprazole | Latin | Australia |
| APX-PANTOPRAZOLE | Latin | Australia |
| BTC Pantoprazole | Latin | Australia |
| Ozpan | Latin | Australia |
| Panthron | Latin | Australia |
| Pantoprazole generichealth | Latin | Australia |
| Pantoprazole Sandoz | Latin | Australia |
| PANTOPRAZOLE-WGR | Latin | Australia |
| Salpraz | Latin | Australia |
| Sozol | Latin | Australia |
| I-Pantoprazole | Latin | Australia |
| Pantrox | Latin | Saudi Arabia |
| PANTOMAX | Latin | Bahrain |
| PROTON IV | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02241804 |
|---|---|
| Brand name | PANTOLOC |
| Generic / active ingredient | PANTOPRAZOLE (PANTOPRAZOLE SODIUM) : 20 MG |
| Manufacturer | TAKEDA CANADA INC |
| Strength | 20 MG |
| Dosage form | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A02BC02 PANTOPRAZOLE |
| AHFS class | 56:28.36 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 09-Jan-2013 |
| Original market date | 2000-05-02 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02241804 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2241804 |
| Brand name | PANTOLOC |
| Active ingredient / INN | PANTOPRAZOLE (PANTOPRAZOLE SODIUM) : 20 MG |
| ATC code | A02BC02 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02 |
| AHFS class | 56:28.36 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | TAKEDA CANADA INC |
How is it stored and handled?
null
How is it supplied?
Tablets are available in bottles of 2, 14, 28, and 100, and blister packs of 2, 7, 14, 28, and 100 tablets. Not all pack sizes may be marketed.
Which pack is which?
| Strength on the label | 20 MG |
|---|---|
| Dosage form | TABLET (ENTERIC-COATED) |
| Route | ORAL |
| Packaging as described in the monograph | Tablets are available in bottles of 2, 14, 28, and 100, and blister packs of 2, 7, 14, 28, and 100 tablets. Not all pack sizes may be marketed. |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Is PANTOPRAZOLE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SIVEM PHARMACEUTICALS ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A02BC02 PANTOPRAZOLE. 39 of 98 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-PANTOPRAZOLE SODIUM | 40 MG | TABLET (DELAYED-RELEASE) | ANGITA PHARMA INC. | MARKETED | DIN 02481588 |
| APO-PANTOPRAZOLE | 20 MG | TABLET (DELAYED-RELEASE) | APOTEX INC | MARKETED | DIN 02292912 |
| APO-PANTOPRAZOLE | 40 MG | TABLET (DELAYED-RELEASE) | APOTEX INC | MARKETED | DIN 02292920 |
| AURO-PANTOPRAZOLE | 40 MG | TABLET (DELAYED-RELEASE) | AURO PHARMA INC | MARKETED | DIN 02415208 |
| BIO-PANTOPRAZOLE | 40 MG | TABLET (DELAYED-RELEASE) | BIOMED PHARMA | MARKETED | DIN 02445867 |
| JAMP PANTOPRAZOLE SODIUM | 20 MG | TABLET (DELAYED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02392615 |
| JAMP PANTOPRAZOLE SODIUM | 40 MG | TABLET (DELAYED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02392623 |
| JAMP-PANTOPRAZOLE | 40 MG | TABLET (DELAYED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02357054 |
| M-PANTOPRAZOLE | 40 MG | TABLET (DELAYED-RELEASE) | MANTRA PHARMA INC | MARKETED | DIN 02467372 |
| MAR-PANTOPRAZOLE | 40 MG | TABLET (DELAYED-RELEASE) | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02416565 |
Who else supplies PANTOPRAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PANTOPRAZOLE appears in 1645 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does PANTOPRAZOLE cost around the world?
PANTOPRAZOLE is listed on 9 national price registers Nexara tracks, across 294 pack listings published on 8 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Australia | ex-manufacturer | 12 | 113 | 08 Sep 2026 |
| South Africa | single exit price | 53 | 68 | 01 Sep 2026 |
| Saudi Arabia | public | 34 | 58 | 01 Sep 2026 |
| Bahrain | retail (max) | 9 | 17 | 01 Sep 2026 |
| Greece | producer price (ex-factory) | 17 | 17 | 03 Sep 2026 |
| United States | acquisition | 1 | 11 | 03 Sep 2026 |
| Morocco | PPV (public price) | 5 | 6 | 05 Sep 2026 |
| United Kingdom | hospital | 3 | 3 | 31 Aug 2026 |
| United Arab Emirates | public | 1 | 1 | 31 Aug 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.